NCT02876146View on ClinicalTrials.gov

Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Alveolar Echinococcosis
Interventions
DRUG

Benzimidazole

Withdrawal of benzimidazole after 4 years (non operable AE) or one year after surgery (curative hepatectomy)

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02876146 - Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole | Biotech Hunter | Biotech Hunter